BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 31534518)

  • 1. Inhibition of HSP90β Improves Lipid Disorders by Promoting Mature SREBPs Degradation via the Ubiquitin-proteasome System.
    Zheng ZG; Zhang X; Liu XX; Jin XX; Dai L; Cheng HM; Jing D; Thu PM; Zhang M; Li H; Zhu J; Liu C; Xue B; Li Y; Chen L; Peng C; Zhu W; Wang L; Liu J; Li HJ; Li P; Xu X
    Theranostics; 2019; 9(20):5769-5783. PubMed ID: 31534518
    [No Abstract]   [Full Text] [Related]  

  • 2. Gkongensin A, an HSP90β inhibitor, improves hyperlipidemia, hepatic steatosis, and insulin resistance.
    Miao K; Zhao Y; Xue N
    Heliyon; 2024 Apr; 10(8):e29367. PubMed ID: 38655315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 7-aminocephalosporanic acid, a novel HSP90β inhibitor, attenuates HFD-induced hepatic steatosis.
    Zhang W; Xue H; Zhou C; Zheng Z; Xing M; Chu H; Li P; Zhang N; Dang Y; Xu X
    Biochem Biophys Res Commun; 2022 Sep; 622():184-191. PubMed ID: 35932530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heat Shock Protein 90 Modulates Lipid Homeostasis by Regulating the Stability and Function of Sterol Regulatory Element-binding Protein (SREBP) and SREBP Cleavage-activating Protein.
    Kuan YC; Hashidume T; Shibata T; Uchida K; Shimizu M; Inoue J; Sato R
    J Biol Chem; 2017 Feb; 292(7):3016-3028. PubMed ID: 28003358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoxanthohumol stimulates ubiquitin-proteasome-dependent degradation of precursor forms of sterol regulatory element-binding proteins.
    Inoue J; Miyata S; Shimizu M; Sato R
    Biosci Biotechnol Biochem; 2018 Sep; 82(9):1591-1598. PubMed ID: 29804513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating Hsp90 Isoform Levels in Overweight and Obese Children and the Relation to Nonalcoholic Fatty Liver Disease: Results from a Cross-Sectional Study.
    Bălănescu A; Stan I; Codreanu I; Comănici V; Bălănescu E; Bălănescu P
    Dis Markers; 2019; 2019():9560247. PubMed ID: 31885746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Andrographolide prevents high-fat diet-induced obesity in C57BL/6 mice by suppressing the sterol regulatory element-binding protein pathway.
    Ding L; Li J; Song B; Xiao X; Huang W; Zhang B; Tang X; Qi M; Yang Q; Yang Q; Yang L; Wang Z
    J Pharmacol Exp Ther; 2014 Nov; 351(2):474-83. PubMed ID: 25204338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gambogic acid identifies an isoform-specific druggable pocket in the middle domain of Hsp90β.
    Yim KH; Prince TL; Qu S; Bai F; Jennings PA; Onuchic JN; Theodorakis EA; Neckers L
    Proc Natl Acad Sci U S A; 2016 Aug; 113(33):E4801-9. PubMed ID: 27466407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of CLC-1 chloride channel biosynthesis by FKBP8 and Hsp90β.
    Peng YJ; Huang JJ; Wu HH; Hsieh HY; Wu CY; Chen SC; Chen TY; Tang CY
    Sci Rep; 2016 Sep; 6():32444. PubMed ID: 27580824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Derlin-1 ameliorates nonalcoholic hepatic steatosis by promoting ubiquitylation and degradation of FABP1.
    You H; Wen X; Wang X; Zhu C; Chen H; Bu L; Zhang J; Qu S
    Free Radic Biol Med; 2023 Oct; 207():260-271. PubMed ID: 37499886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ubiquitin Ligase COP1 Controls Hepatic Fat Metabolism by Targeting ATGL for Degradation.
    Ghosh M; Niyogi S; Bhattacharyya M; Adak M; Nayak DK; Chakrabarti S; Chakrabarti P
    Diabetes; 2016 Dec; 65(12):3561-3572. PubMed ID: 27658392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expressed as the sole Hsp90 of yeast, the alpha and beta isoforms of human Hsp90 differ with regard to their capacities for activation of certain client proteins, whereas only Hsp90beta generates sensitivity to the Hsp90 inhibitor radicicol.
    Millson SH; Truman AW; Rácz A; Hu B; Panaretou B; Nuttall J; Mollapour M; Söti C; Piper PW
    FEBS J; 2007 Sep; 274(17):4453-63. PubMed ID: 17681020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emodin improves lipid and glucose metabolism in high fat diet-induced obese mice through regulating SREBP pathway.
    Li J; Ding L; Song B; Xiao X; Qi M; Yang Q; Yang Q; Tang X; Wang Z; Yang L
    Eur J Pharmacol; 2016 Jan; 770():99-109. PubMed ID: 26626587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hsp90 modulates PPARγ activity in a mouse model of nonalcoholic fatty liver disease.
    Wheeler MC; Gekakis N
    J Lipid Res; 2014 Aug; 55(8):1702-10. PubMed ID: 24927728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HSP90β chaperoning SMURF1-mediated LATS proteasomal degradation in the regulation of bone formation.
    Qu M; Gong Y; Jin Y; Gao R; He Q; Xu Y; Shen T; Mei L; Xu C; Hussain M; Barkat MQ; Wu X
    Cell Signal; 2023 Feb; 102():110523. PubMed ID: 36379376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cks1 proteasomal degradation is induced by inhibiting Hsp90-mediated chaperoning in cancer cells.
    Khattar V; Fried J; Xu B; Thottassery JV
    Cancer Chemother Pharmacol; 2015 Feb; 75(2):411-20. PubMed ID: 25544127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opposite effect of Hsp90α and Hsp90β on eNOS ability to produce nitric oxide or superoxide anion in human embryonic kidney cells.
    Cortes-González C; Barrera-Chimal J; Ibarra-Sánchez M; Gilbert M; Gamba G; Zentella A; Flores ME; Bobadilla NA
    Cell Physiol Biochem; 2010; 26(4-5):657-68. PubMed ID: 21063103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Client Proteins and Small Molecule Inhibitors Display Distinct Binding Preferences for Constitutive and Stress-Induced HSP90 Isoforms and Their Conformationally Restricted Mutants.
    Prince TL; Kijima T; Tatokoro M; Lee S; Tsutsumi S; Yim K; Rivas C; Alarcon S; Schwartz H; Khamit-Kush K; Scroggins BT; Beebe K; Trepel JB; Neckers L
    PLoS One; 2015; 10(10):e0141786. PubMed ID: 26517842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schisandra polysaccharide inhibits hepatic lipid accumulation by downregulating expression of SREBPs in NAFLD mice.
    Wang CM; Yuan RS; Zhuang WY; Sun JH; Wu JY; Li H; Chen JG
    Lipids Health Dis; 2016 Nov; 15(1):195. PubMed ID: 27852305
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Tong J; Tan S; Nikolovska-Coleska Z; Yu J; Zou F; Zhang L
    Mol Cancer Ther; 2017 Sep; 16(9):1979-1988. PubMed ID: 28619760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.